A comprehensive view of Drug Delivery/Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

American Regent launches FDA-approved injectable Atropine Sulfate; drug serves as temporary blockade of severe, life-threatening muscarinic effects, as an organophosphorus, muscarinic mushroom poisoning antidote, and to treat bradyasystolic cardiac arrest

Assure Infusions building 60,000 square-foot, fully automated IV fluid manufacturing plant in Bartow, Florida, to open in 2023; Assure launched in 2022 to make sterile IV fluids such as dextrose, Ringer’s lactate, normal saline, sterile water

Aptar Pharma acquires worldwide license for Orbital Dry Powder Inhaler from Pharmaxis for undisclosed amount; high payload Orbital technology delivers up to 400 mg of powders in divided doses without the need to reload

Amgen acquiring biopharmaceutical firm ChemoCentryx for US$3.7B, with deal to close in Q4 2022; ChemoCentryx’s drugs include oral Tavneos to treat severe active ANCA-associated vasculitis and three candidates to treat inflammatory diseases, cancer

FDA to conduct clinical trial of Siga Technologies’ Tpoxx tecovirimat oral and injectable antiviral as a treatment for monkeypox; CDC reports 7,510 monkeypox cases in US

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count